Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits
KM Thrailkill, RC Bunn, S Uppuganti, P Ray, I Popescu… - Bone, 2020 - Elsevier
Higher fracture risk in type 2 diabetes (T2D) is attributed to disease-specific deficits in micro-
structural and material properties of bone, although the primary cause is not yet established …
structural and material properties of bone, although the primary cause is not yet established …